FAQs
Which dose should be used?
Maximum recommended total dose of doxorubicin per procedure is 150mg. PRECISION I included a dose escalation study up to 150mg doxorubicin and the 150mg dose was safe and effective. There were no dose-related adverse events. The tumour response rate at 6 months was 87% at this dose.
In Precision V, Biocompatibles' phase III randomised controlled clinical trial, the dose is 150mg.
A dose of up to 37.5mg doxorubicin per ml DC Beads can be loaded. 150mg in 4 to 6ml DC Bead.
In this section
Disclaimer
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.